Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Short Interest


SHSE:603168 Zhejiang Shapuaisi Pharmaceutical Co Ltd SHSE:603168
37 GF Score
Price ¥4.97
GF Value ¥8.59
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zhejiang Shapuaisi Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:603168 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shapuaisi Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Shapuaisi Pharmaceutical Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shapuaisi Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Zhejiang Shapuaisi Pharmaceutical Co's Short Interest falls into.


SHSE:603168
37GF Score
Zhejiang Shapuaisi Pharmaceutical Co Ltd SHSE:603168
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥4.97 is trading 42.1% below its estimated GF Value™ of ¥8.59. GuruFocus considers Zhejiang Shapuaisi Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:603168:

  • Short Interest:
  • GF Value™: ¥8.59 vs. price of ¥4.97 (42.1% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Address No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
37GF Score

Get the complete analysis for SHSE:603168

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.97
Price
¥8.59
GF Value